Abstract
Purpose
The purpose of the study was to examine if a minimum of 12 lymph nodes (LNs) is still valid in rectal cancer after neo-adjuvant treatment.
Methods
An analysis was carried out in a nationwide Danish cohort of 6793 patients, treated by curative resection of stage I–III rectal cancer during the period 2003–2011. The cohort was divided into two groups according to whether neo-adjuvant treatment had been given. The groups were analysed separately and were further analysed according to four lymph node yield (LNY) groups 0–5, 6–11, 12–17 and ≥18.
Results
Two thousand one hundred twenty-three patients (31.0 %) received neo-adjuvant treatment. A median LNY of 10 and 15 (p < 0.0001) and rates of node-positive (N-positive) disease of 31.6 and 36.7 % (p < 0.001) were observed with and without (+/−) neo-adjuvant treatment, respectively. The rate of N-positive disease according to tumour stage ranged from 4.8 %/11.4 % (ypT0/pT1) to 42.1 %/64.1 % (ypT4/pT4). The rate of N-positive disease according to LNY ranged from 19.5 %/16.8 % (0–5 LNs) to 42.6 %/37.9 % (≥18 LNs) (−/+neo-adjuvant treatment). In a logistic regression analysis, a significant association was found between N-positive disease and pT/ypT stage as well as between N-positive disease and LNY.
Conclusions
A significantly smaller ratio of N-positive disease was observed in the group of patients who had received neo-adjuvant treatment. The ratio of N-positive disease increased significantly with more advanced tumour stage and increasing LNY irrespective of neo-adjuvant treatment. A minimum of 12 LNs is needed to ensure N-negative disease, irrespective of neo-adjuvant treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474. doi:10.1245/s10434-010-0985-4
Fielding LP, Arsenault PA, Chapuis PH et al (1991) Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol 6:325–344
Nelson H, Petrelli N, Carlin A et al (2001) Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93:583–596
Pickren JW (1975) Current concepts in cancer. Nodal clearance and detection. JAMA 231:969–971
Scott KW, Grace RH (1989) Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 76:1165–1167
Cawthorn SJ, Gibbs NM, Marks CG (1986) Clearance technique for the detection of lymph nodes in colorectal cancer. Br J Surg 73:58–60
Govindarajan A, Gonen M, Weiser MR et al (2011) Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol 29:4568–4573
Kidner TB, Ozao-Choy JJ, Yoon J, Bilchik AJ (2012) Should quality measures for lymph node dissection in colon cancer be extrapolated to rectal cancer? Am J Surg 204:843–848. doi:10.1016/j.amjsurg.2012.05.003
Wong JH, Severino R, Honnebier MB et al (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 17:2896–2900
Yao Y-F, Wang L, Liu Y-Q et al (2011) Lymph node distribution and pattern of metastases in the mesorectum following total mesorectal excision using the modified fat clearing technique. J Clin Pathol 64:1073–1077. doi:10.1136/jclinpath-2011-200190
Awwad GEH, Tou SIH, Rieger NA (2013) Prognostic significance of lymph node yield after long-course preoperative radiotherapy in patients with rectal cancer: a systematic review. Colorectal Dis 15:394–403. doi:10.1111/codi.12011
Petersen SH, Harling H, Kirkeby LT et al (2012) Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev 3, CD004078
Benson AB III, Schrag D, Somerfield MR et al (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22:3408–3419
http://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf. http://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf.
Lykke J, Roikjaer O, Jess P (2013) Tumour stage and preoperative chemoradiotherapy influence the lymph node yield in stages I-Iii rectal cancer: results from a prospective nationwide cohort study. Colorectal Dis. doi:10.1111/codi.12521
De la Fuente SG, Manson RJ, Ludwig KA, Mantyh CR (2009) Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens. J Gastrointest Surg 13:269–274
Francois Y, Nemoz CJ, Baulieux J et al (1999) Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 17:2396
Miller ED, Robb BW, Cummings OW, Johnstone PA (2012) The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer. Dis Colon Rectum 55:1002–1007
Ha YH, Jeong S-Y, Lim S-B et al (2010) Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer. Ann Surg 252:336–340. doi:10.1097/SLA.0b013e3181e61e33
DCCG Annual Report 2011. http://www.dccg.dk/03_Publikation/02_arsraport_pdf/aarsrapport_2011.pdf. Accessed 27 May 2013
DCCG Anual Repport 2001-2. http://www.dccg.dk/03_Publikation/02_arsraport_pdf/KRC_aarsrapport2001_2002.pdf. Accessed 12 Sep 2014
DCCG nationale guidlines. http://www.dccg.dk/retningslinjer/indeks.html. Accessed 16 Feb 2014
Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646
Rullier E, Goffre B, Bonnel C et al (2001) Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg 234:633–640
Cianchi F, Palomba A, Boddi V et al (2002) Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World JSurg 26:384–389
Pucciarelli S, Capirci C, Emanuele U et al (2005) Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg Oncol 12:111–116. doi:10.1245/ASO.2005.03.044
Danish Colorectal Cancer Group (DCCG).2012. http://www.dccg.dk/. Accessed 20 May 2013
Berho M, Oviedo M, Stone E et al (2009) The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer. Colorectal Dis 11:254–258. doi:10.1111/j.1463-1318.2008.01597.x
Scott N (2004) Lymph node retrieval after neoadjuvant radiotherapy for rectal adenocarcinoma. J Clin Pathol 57:335–336. doi:10.1136/jcp.2003.013441
McDonald JR, Renehan AG, O’Dwyer ST, Haboubi NY (2012) Lymph node harvest in colon and rectal cancer: current considerations. World J Gastrointest Surg 4:9–19
Acknowledgements
Contributions from local surgical representatives of the Danish Colorectal Cancer Group are gratefully acknowledged.
Conflicts of interests
There are no conflicts of interests.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Lykke, J., Jess, P., Roikjaer, O. et al. A minimum yield of twelve lymph nodes in rectal cancer remains valid in the era of neo-adjuvant treatment. Int J Colorectal Dis 30, 347–351 (2015). https://doi.org/10.1007/s00384-015-2145-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-015-2145-6